The Role of Natriuretic Peptides: From the Emergency Department Throughout Hospitalization

Peter Pang, Yang Xue, Christopher Defilippi, Marc Silver, James Januzzi, Alan Maisel

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Assessment of natriuretic peptide (NP) levels has a well-established role in the diagnosis and prognosis of acute heart failure (AHF) patients. Current guidelines recommend assessment of NPs when the diagnosis is in question, yet multiple studies suggest a broader value of NP assessment. Measurement of NP levels results in more efficient treatment, resource utilization (ie, reduced costs), and possibly improved short- and long-term outcomes. Given the large number of patients hospitalized every year with heart failure, combined with the high post-discharge mortality, rehospitalization rates, and subsequent large financial costs, improving outcomes for hospitalized HF patients remains an unmet need. In this review, we highlight the value of NP assessment, starting in the emergency department and throughout hospitalization. The contents of this review were generated from a roundtable discussion of AHF and biomarker experts held in Chicago in April 2012 and focused on addressing the burden of AHF and readmission.

Original languageEnglish (US)
JournalCongestive Heart Failure
Volume18
Issue numberSUPPL. 1
DOIs
StatePublished - Sep 2012
Externally publishedYes

Fingerprint

Natriuretic Peptides
Hospital Emergency Service
Hospitalization
Heart Failure
Costs and Cost Analysis
Biomarkers
Guidelines
Mortality
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Emergency Medicine
  • Emergency

Cite this

The Role of Natriuretic Peptides : From the Emergency Department Throughout Hospitalization. / Pang, Peter; Xue, Yang; Defilippi, Christopher; Silver, Marc; Januzzi, James; Maisel, Alan.

In: Congestive Heart Failure, Vol. 18, No. SUPPL. 1, 09.2012.

Research output: Contribution to journalArticle

Pang, Peter ; Xue, Yang ; Defilippi, Christopher ; Silver, Marc ; Januzzi, James ; Maisel, Alan. / The Role of Natriuretic Peptides : From the Emergency Department Throughout Hospitalization. In: Congestive Heart Failure. 2012 ; Vol. 18, No. SUPPL. 1.
@article{7b7a763372ee406eb8cab9815e4db829,
title = "The Role of Natriuretic Peptides: From the Emergency Department Throughout Hospitalization",
abstract = "Assessment of natriuretic peptide (NP) levels has a well-established role in the diagnosis and prognosis of acute heart failure (AHF) patients. Current guidelines recommend assessment of NPs when the diagnosis is in question, yet multiple studies suggest a broader value of NP assessment. Measurement of NP levels results in more efficient treatment, resource utilization (ie, reduced costs), and possibly improved short- and long-term outcomes. Given the large number of patients hospitalized every year with heart failure, combined with the high post-discharge mortality, rehospitalization rates, and subsequent large financial costs, improving outcomes for hospitalized HF patients remains an unmet need. In this review, we highlight the value of NP assessment, starting in the emergency department and throughout hospitalization. The contents of this review were generated from a roundtable discussion of AHF and biomarker experts held in Chicago in April 2012 and focused on addressing the burden of AHF and readmission.",
author = "Peter Pang and Yang Xue and Christopher Defilippi and Marc Silver and James Januzzi and Alan Maisel",
year = "2012",
month = "9",
doi = "10.1111/j.1751-7133.2012.00307.x",
language = "English (US)",
volume = "18",
journal = "Congestive Heart Failure",
issn = "1527-5299",
publisher = "Wiley-Blackwell",
number = "SUPPL. 1",

}

TY - JOUR

T1 - The Role of Natriuretic Peptides

T2 - From the Emergency Department Throughout Hospitalization

AU - Pang, Peter

AU - Xue, Yang

AU - Defilippi, Christopher

AU - Silver, Marc

AU - Januzzi, James

AU - Maisel, Alan

PY - 2012/9

Y1 - 2012/9

N2 - Assessment of natriuretic peptide (NP) levels has a well-established role in the diagnosis and prognosis of acute heart failure (AHF) patients. Current guidelines recommend assessment of NPs when the diagnosis is in question, yet multiple studies suggest a broader value of NP assessment. Measurement of NP levels results in more efficient treatment, resource utilization (ie, reduced costs), and possibly improved short- and long-term outcomes. Given the large number of patients hospitalized every year with heart failure, combined with the high post-discharge mortality, rehospitalization rates, and subsequent large financial costs, improving outcomes for hospitalized HF patients remains an unmet need. In this review, we highlight the value of NP assessment, starting in the emergency department and throughout hospitalization. The contents of this review were generated from a roundtable discussion of AHF and biomarker experts held in Chicago in April 2012 and focused on addressing the burden of AHF and readmission.

AB - Assessment of natriuretic peptide (NP) levels has a well-established role in the diagnosis and prognosis of acute heart failure (AHF) patients. Current guidelines recommend assessment of NPs when the diagnosis is in question, yet multiple studies suggest a broader value of NP assessment. Measurement of NP levels results in more efficient treatment, resource utilization (ie, reduced costs), and possibly improved short- and long-term outcomes. Given the large number of patients hospitalized every year with heart failure, combined with the high post-discharge mortality, rehospitalization rates, and subsequent large financial costs, improving outcomes for hospitalized HF patients remains an unmet need. In this review, we highlight the value of NP assessment, starting in the emergency department and throughout hospitalization. The contents of this review were generated from a roundtable discussion of AHF and biomarker experts held in Chicago in April 2012 and focused on addressing the burden of AHF and readmission.

UR - http://www.scopus.com/inward/record.url?scp=84865304803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865304803&partnerID=8YFLogxK

U2 - 10.1111/j.1751-7133.2012.00307.x

DO - 10.1111/j.1751-7133.2012.00307.x

M3 - Article

C2 - 22891802

AN - SCOPUS:84865304803

VL - 18

JO - Congestive Heart Failure

JF - Congestive Heart Failure

SN - 1527-5299

IS - SUPPL. 1

ER -